Epilepsy, Progressive Myoclonus Type 2A (Lafora Disease, EPM2A, Laforin, LD, LDE, EPM2, MELF, LAFPTPase, FLJ11207, KIAA0766)
Katalog-Nummer E3384-75-100ug
Size : 100ug
Marke : US Biological
Contact local distributor :
Telefonnummer : +1 850 650 7790
E3384-75 Epilepsy, Progressive Myoclonus Type 2A (Lafora Disease, EPM2A, Laforin, LD, LDE, EPM2, MELF, LAFPTPase, FLJ11207, KIAA0766)
Clone Type
PolyclonalHost
mouseSource
humanIsotype
IgG1Grade
Affinity PurifiedApplications
WBCrossreactivity
HuAccession #
NM_005670Shipping Temp
Blue IceStorage Temp
-20°CApplications: |Suitable for use in Western Blot. Other applications not tested.||Recommended Dilution:|Western Blot: 1:1000-1:2000|Optimal dilutions to be determined by the researcher.||Storage and Stability:|May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Applications
Product Type: Mab|Isotype: IgG1|Clone No: 8C130|Host: mouse|Source: human|Concentration: ~0.1mg/ml|Form: Supplied as a liquid in PBS, pH 7.4, 1% BSA, 0.05% sodium azide.|Purity: Purified by Protein G affinity chromatography from hybridoma culture supernatant|Immunogen: Partial sequence of recombinant full-length protein to human Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease|Specificity: Recognizes human Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease.||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Immunogen
Partial recombinant protein corresponding to human Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease
Form
Supplied as a liquid in PBS, pH 7.4, 1% BSA, 0.05% sodium azide.
Purity
Purified by Protein G affinity chromatography from hybridoma culture supernatant
Specificity
Recognizes human Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease.